{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:58Z","timestamp":1761663178836},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-374","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T07:33:35Z","timestamp":1376552015000},"source":"Crossref","is-referenced-by-count":15,"title":["HCV infected prisoners: should they be still considered a difficult to treat population?"],"prefix":"10.1186","volume":"13","author":[{"given":"Fabio","family":"Iacomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Iannicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Migliorisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluca","family":"Piselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"De Carli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Marcellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"2583_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/00365540903095358","volume":"41","author":"A Mariano","year":"2009","unstructured":"Mariano A, Tomba GS, Tosti ME, Spada E, Mele A: Estimating the incidence, prevalence and clinical burden of hepatitis C over time. Scand J Inf Dis. 2009, 41: 689-699. 10.1080\/00365540903095358.","journal-title":"Scand J Inf Dis"},{"key":"2583_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2334-13-81","volume":"13","author":"JMS Hanh\u00e8","year":"2013","unstructured":"Hanh\u00e8 JMS, Veldhuijzen IK, Wiessing L, Lim TA, Salminem M, Laar M: Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Inf Dis. 2013, 13: 81-10.1186\/1471-2334-13-81.","journal-title":"BMC Inf Dis"},{"key":"2583_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jmv.20375","volume":"76","author":"S Babudieri","year":"2005","unstructured":"Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sandu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G: Correlates of HIV, HBV, HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005, 76: 311-317. 10.1002\/jmv.20375.","journal-title":"J Med Virol"},{"key":"2583_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1572-0241.2004.30310.x","volume":"99","author":"RK Sterling","year":"2004","unstructured":"Sterling RK, Hofmann CM, Luketic VA, Sanyal AJ, Contos MJ, Millas AS, Shiffman ML: Treatment of chronic hepatitis C virus in the Virginia department of corrections: can compliance overcome racial differences to response?. Am J of Gastroenterol. 2004, 99: 866-872. 10.1111\/j.1572-0241.2004.30310.x.","journal-title":"Am J of Gastroenterol"},{"key":"2583_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1155\/2005\/767540","volume":"19","author":"JD Farley","year":"2005","unstructured":"Farley JD, Wong VK, Chung HV, Lim E, Gavin W, Farley TA, Yoshida EM: Treatment of chronic hepatitis C in Canadian prison inmates. Can J Gastroenterol. 2005, 19: 153-156.","journal-title":"Can J Gastroenterol"},{"key":"2583_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2105\/AJPH.2004.056150","volume":"95","author":"JD Farley","year":"2005","unstructured":"Farley JD, Vasdev S, Fischer B, Haydon E, Rahn J, Farley TA: Feasibility and outcome of HCV treatment in a Canadian federal prison. Am J of Public Health. 2005, 95: 1737-1739. 10.2105\/AJPH.2004.056150.","journal-title":"Am J of Public Health"},{"key":"2583_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1086\/591707","volume":"47","author":"DS Maru","year":"2008","unstructured":"Maru DS, Bruce RD, Basu S, Altice FL: Clinical outcomes of hepatitis C treatmentin a prison setting: feasibility and effectiveness for challenging treatment populations. CID. 2008, 47: 952-961. 10.1086\/591707.","journal-title":"CID"},{"key":"2583_CR8","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10620-008-0483-8","volume":"54","author":"P Strock","year":"2009","unstructured":"Strock P, Mossong J, Hawotte K, Arendt V: Access to treatment of hepatitis C in prison inmates. Dig Dis Sci. 2009, 54: 1325-1330. 10.1007\/s10620-008-0483-8.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2583_CR9","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/hep.25770","volume":"56","author":"JP Rice","year":"2012","unstructured":"Rice JP, Burnett D, Tsotis E, Lindstrom M, Cornett DD, Voermans P, Sawyer J, Striker R, Lucey MR: Comparison of hepatitis C virus treatment between incarcerated and community patients. Hepatology. 2012, 56 (4): 1252-1260. 10.1002\/hep.25770.","journal-title":"Hepatology"},{"key":"2583_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7326\/0003-4819-138-3-200302040-00010","volume":"138","author":"SA Allen","year":"2003","unstructured":"Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD: Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003, 138: 187-190. 10.7326\/0003-4819-138-3-200302040-00010.","journal-title":"Ann Intern Med"},{"key":"2583_CR11","volume-title":"Hepatology","author":"S Larney","year":"2013","unstructured":"Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, Van Den Bergh BJ, Degenhardt L: The incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta- analysis. Hepatology. 2013, 10.1002\/hep.26387. Epub ahead of print"},{"key":"2583_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10096-011-1166-5","volume":"30","author":"PS De La Hoya","year":"2011","unstructured":"De La Hoya PS, Marco A, Garc\u00eda-Guerrero J, Rivera A, on behalf of the Prevalhep study group: Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011, 30: 857-862. 10.1007\/s10096-011-1166-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2583_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1590\/S1413-86702006000400012","volume":"10","author":"S Sabbatani","year":"2006","unstructured":"Sabbatani S, Giuliani R, Manfredi R: Combined pegylated interferon and Ribavirin for the management of chronic hepatitis C in a prison setting. Braz J Infect Dis. 2006, 10: 274-278. 10.1590\/S1413-86702006000400012.","journal-title":"Braz J Infect Dis"},{"key":"2583_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.dld.2010.12.004","volume":"43","author":"PL Almasio","year":"2011","unstructured":"Almasio PL, Baudieri S, Barbarini G, Brunetto M, Conte D, Dentico P, Gaeta GB, Leonardi C, Levrero M, Mazzotta F, Morrone A, Nosotti L, Prati D, Rapicetta M, Sagnelli E, Scotto G, Starnini G: Recommendations for the prevention, diagnosis, and treatment of chronic epatiti B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liv Dis. 2011, 43: 589-595. 10.1016\/j.dld.2010.12.004.","journal-title":"Dig Liv Dis"},{"issue":"suppl 1","key":"2583_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1478-3231.2011.02703.x","volume":"32","author":"V Calvaruso","year":"2012","unstructured":"Calvaruso V, Crax\u00ec A: 2011 European association of the study of the liver hepatitis C virus clinical practice guidelines. Liver Int. 2012, 32 (suppl 1): 2-8.","journal-title":"Liver Int"},{"key":"2583_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996, 24: 289-293. 10.1002\/hep.510240201.","journal-title":"Hepatology"},{"key":"2583_CR17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"4","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB: Diagnosis, management and treatment of hepatitis C: an update. Hepatology. 2009, 4: 1335-1374.","journal-title":"Hepatology"},{"key":"2583_CR18","first-page":"68","volume":"76","author":"Agenzia Italiana del Farmaco (AIFA)","year":"2008","unstructured":"Agenzia Italiana del Farmaco (AIFA): Guidelines for the classification and management of observational studies. Gazzetta Ufficiale della Repubblica Italiana. 2008, 76: 68-74.","journal-title":"Gazzetta Ufficiale della Repubblica Italiana"},{"key":"2583_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling MH, Albrecht J, the international hepatitis Interventional therapy: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. The Lancet. 2001, 358: 958-965. 10.1016\/S0140-6736(01)06102-5.","journal-title":"The Lancet"},{"key":"2583_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales F, H\u00e4ussiger D, Diago M, Carosi G, Dhumeaux D, Crax\u00ec A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002, 347: 975-982. 10.1056\/NEJMoa020047.","journal-title":"N Engl J Med"},{"key":"2583_CR21","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/01.mcg.0000145538.43865.72","volume":"39","author":"BP Mulhall","year":"2005","unstructured":"Mulhall BP, Younossi Z: Impact of adherence on outcome of antiviral therapy for chronic hepatitis C. J Clin Gastroenterol. 2005, 39: S23-S27. 10.1097\/01.mcg.0000145538.43865.72.","journal-title":"J Clin Gastroenterol"},{"key":"2583_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","volume":"140","author":"SJ Hadziyannis","year":"2004","unstructured":"Hadziyannis SJ, Sette H, Morgan TR, Balan V, Diago M, Marcellin P, Ramadoro G, Bodenheimer H, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM: Peginterferon-alfa-2a and ribavirin combination therapy in chronic hepatitis C. Ann Intern Med. 2004, 140: 346-355. 10.7326\/0003-4819-140-5-200403020-00010.","journal-title":"Ann Intern Med"},{"key":"2583_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","volume":"20","author":"JA Morrill","year":"2005","unstructured":"Morrill JA, Shrestha M, Grant RW: Barriers to the treatment of hepatitis C. Patients, provider, and system factors. J Gen Intern Med. 2005, 20: 754-758. 10.1111\/j.1525-1497.2005.0161.x.","journal-title":"J Gen Intern Med"},{"key":"2583_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2893.2005.00547.x","volume":"12","author":"AA Butt","year":"2005","unstructured":"Butt AA, Wagener M, Shakil AO, Ahmad J: Reasons for non-treatment of Hepatitis C in veterans in care. J Viral Hepat. 2005, 12: 81-85. 10.1111\/j.1365-2893.2005.00547.x.","journal-title":"J Viral Hepat"},{"key":"2583_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1089\/aid.2011.0004","volume":"27","author":"AA Butt","year":"2011","unstructured":"Butt AA, McGinnis K, Skanderson M, Justice AC: A comparison of treatment Eligibility for hepatitis C virus in HCV-monoinfected versus HCV\/HIV-coinfected persons in electronically retrieved cohort of HCV veterans. AIDS Res Hum Retroviruses. 2011, 27: 973-979. 10.1089\/aid.2011.0004.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2583_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.dld.2008.11.011","volume":"41","author":"A Mariano","year":"2009","unstructured":"Mariano A, Caserta C, Pendino GM, Vacalebre C, Surace P, Fiorillo MT, Polito I, Surace M, Alicante S, Amante A, Foti G, Marra M, Gutamo G, Amato F, Messineo A, Mele A: Antiviral treatment for heptitis C virus infection: effectiveness at general population level in highly enedemic area. Dig Liv Dis. 2009, 41: 509-515. 10.1016\/j.dld.2008.11.011.","journal-title":"Dig Liv Dis"},{"key":"2583_CR27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","volume":"144","author":"AC Spaulding","year":"2006","unstructured":"Spaulding AC, Weimbaum CM, Sterling R, Seeff LB, Margolis HS, Hoofnagle JH: A framework for management of hepatitis C in prisons. Ann Intern Med. 2006, 144: 762-769. 10.7326\/0003-4819-144-10-200605160-00010.","journal-title":"Ann Intern Med"},{"key":"2583_CR28","volume-title":"Incidence and community prevalence of hiv and other blood borne pathogens among incarcerated women in Rhode Island (Abstract)","author":"GE Macalino","year":"1999","unstructured":"Macalino GE, Salas CM, Towe CW, Foisie CK, McKenzie M, Spaulding A: Incidence and community prevalence of hiv and other blood borne pathogens among incarcerated women in Rhode Island (Abstract). 1999, Atlanta, Georgia: National HIV Prevention Conference, Accessed \n                    http:\/\/www.aegis.org\/conferences\/NHIVPC\/1999\/610.html\n                    \n                   on13 december 2002"},{"key":"2583_CR29","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/hep.24641","volume":"54","author":"MG Ghany","year":"2011","unstructured":"Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB: An update on treatment og genotype 1 chronic hepatitis C virus infection: 2011 practice guidelines by the American Association for the study of liver diseases. Hepatology. 2011, 54: 1433-1443. 10.1002\/hep.24641.","journal-title":"Hepatology"},{"key":"2583_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5694\/mja11.11531","volume":"196","author":"GJ Dore","year":"2012","unstructured":"Dore GJ: The changing therapeutic landscape for hepatitis C. Med J Aus. 2012, 196: 629-632. 10.5694\/mja11.11531.","journal-title":"Med J Aus"},{"key":"2583_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1056\/NEJMoa1104430","volume":"366","author":"AS Lok","year":"2012","unstructured":"Lok AS, Gardiner DF, Lawitz E, Martorell C, Everson GT, Reem G, Reidollar R, Rustgi V, McPhee F, Wind-Rotolo M, Persson A, Zhu K, Dimitrova DI, Eley T, Guong T, Grasela DM, Pasquinelli C: Preliminary study of two antiviral agents for hepatitis C genotype 1. N Engl J Med. 2012, 366: 216-224. 10.1056\/NEJMoa1104430.","journal-title":"N Engl J Med"},{"key":"2583_CR32","first-page":"27","volume":"21","author":"AC Spaulding","year":"2013","unstructured":"Spaulding AC, Kim AY, Harzke JA, Sullivan JC, Linas BP, Brewer A, Dickert J, Mc Govern BH, Strick LB, Trestman R, Ferguson WJ: Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. Top Antivir Med. 2013, 21: 27-35.","journal-title":"Top Antivir Med"},{"key":"2583_CR33","first-page":"161","volume-title":"Annual report to the Italian Parliament on the state of drug addiction","author":"Ministero per la Cooperazione internazionale e l\u2019Integrazione","year":"2011","unstructured":"Ministero per la Cooperazione internazionale e l\u2019Integrazione: Annual report to the Italian Parliament on the state of drug addiction. 2011, 161-182. Accessed at \n                    http:\/\/www.politicheantidroga.it\/progetti-e-ricerca\/relazioni-al-parlamento\/relazione-annuale-2011\/presentazione.aspx\n                    \n                  , , Volume Ch. I.4"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-374\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T12:29:20Z","timestamp":1548246560000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2583"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-374","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]},"article-number":"374"}}